簡易檢索 / 詳目顯示

研究生: 林智苓
Lin, Chi-Leng
論文名稱: 研究關於造牙骨質細胞瘤的病理性及正常 牙骨質細胞標誌
A Study about the Pathogenesis of a Cementoblastoma and Cell Markers of Normal Cementoblast
指導教授: 袁國
Yuan, Kuo
學位類別: 碩士
Master
系所名稱: 醫學院 - 口腔醫學研究所
Institute of Oral Medicine
論文出版年: 2006
畢業學年度: 94
語文別: 中文
論文頁數: 98
中文關鍵詞: 牙骨質細胞瘤牙骨質貼附蛋白人類造牙骨質細胞腫瘤易感受性基因101
外文關鍵詞: cementoblastoma, cementum attachment protein, human cementoblast, tumor susceptibility gene 101
相關次數: 點閱:58下載:3
分享至:
查詢本校圖書館目錄 查詢臺灣博碩士論文知識加值系統 勘誤回報
  • 造牙骨質細胞瘤(cementoblastoma)是一種良性的腫瘤,大多數關於此腫瘤的研究都是病例報告(case reports) 或病理診斷(pathological diagnosis),都沒有對其病理機制作探討。牙骨質(cementum)是貼附在牙根表面上一種獨特礦物質化的結締組織。在牙周再生過程當中扮演著不可缺少的角色。大多數有關於牙周再生的研究顯示,再生的過程中牙骨質的形成是絕對必要的。雖然牙骨質在組織學上已經有明確的界定,但是造牙骨質細胞(cementoblast)仍然沒有被廣為接受的細胞標誌。根據之前的研究,造牙骨質細胞相似骨細胞(osteoblasts)會表現bone sialoprotein (BSP),而齒齦纖維母細胞(gingival fibroblast)和牙周韌帶纖維母細胞
    (periodontal ligament fibroblast, PDL)則不會表現。所以本實驗目的是想要了解造牙骨質細胞瘤的致病機轉及正常牙骨質細胞的細胞標誌。近年來,在造牙骨質瘤細胞培養液中可獲取某種特殊蛋白且可以在正常牙骨質細胞中獨特的表現出來,稱為牙骨質貼附蛋白(cementum attachment protein, CAP)。然而,牙骨質貼附蛋白(CAP)尚未完全的被認可當作造牙骨質細胞的細胞標誌。為了使造牙骨質細胞生物學上的鑑定更加清楚,就必須發展更深入的認識於細胞的表現。在本研究當中,我們利用了牙骨質貼附蛋白(CAP)上一段特殊的序列所生產的多株抗體來確認造牙骨質細胞瘤的細胞會表現牙骨質貼附蛋白(CAP)。隨後,我們使用cDNA
    microarray(一個有力並可以大規模分析的工具)來比較同個病人中造牙骨質細胞瘤細胞(cementoblastoma cell) 和齒齦纖維母細胞(gingivalfibroblast)之間基因表現的差異。在cDNA microarray 的資料中,我們想知道哪個基因在牙骨質細胞瘤細胞表現較高且和腫瘤形成的機制有關。Tumor susceptibility gene 101 (TSG101)只在牙骨質細胞瘤細胞中表現。而
    在牙骨質細胞瘤細胞alkaline phosphatase (ALP)的活性表現量相對高於其他細胞。這些因素可能是造成它病理性的原因。而我們也發現在cDNA microarray 的資料中,junctophilin-2 (JPH2)是在牙骨質瘤細胞裡表現量最高的基因,因此,我們利用西方墨點法確認JPH2 在體外的表現,它是一個特殊分子存在於牙骨質細胞瘤細胞及正常牙骨質細胞。它應可以當作牙骨質細胞標誌的候選分子。我們希望這項研究的結果將可以幫助更加
    詳細瞭解牙骨質的生物性,也許可為未來臨床應用提供有用的資訊。

    A cementoblastoma is a benign tumor. Most cementoblastoma studies are case reports or pathological diagnoses that do not discuss its pathological mechanism. Cementum is a unique mineralized connective tissue that covers
    the root surfaces of the teeth. It is indispensable for periodontal regeneration.
    Although cementum is well-defined histologically, there is no universally-accepted cell marker for the cementoblast. Previous studies suggested that cementoblasts as well as osteoblasts expressed bone sialoprotein (BSP), but that human gingival and periodontal ligament
    fibroblasts did not. The aim of this study was to understand the pathogenesis of a cementoblastoma and the cell markers of a normal cementoblast.Recently, a protein isolated from the conditioned medium of cementoblastoma
    culture was uniquely expressed by cementoblasts and called “cementum attachment protein (CAP)”. However, CAP is not yet unequivocally accepted as the cell marker for a cementoblast. To clarify the biological identity of the
    cementoblast, it is necessary to develop a deeper understanding of its expression profile. In the present study, we produced a polyclonal antibody against a specific CAP sequence to confirm that a cementoblastoma expressed
    CAP. Subsequently, we used a cDNA microarray, a powerful large-scale screening tool, to compare the differences in expression between a human
    cementoblastoma cell and a human gingival fibroblast from the same patient.
    In addition to the cDNA microarray data, we wanted to know which genes were upregulated in cementoblastomas, and we wanted to learn more about the mechanism of tumorigenesis. The tumor susceptibility gene 101 (TSG101) was overexpressed only in cementoblastomas. ALP activity in cementoblastomas was relatively higher than in other cells. That might be the
    reason for its pathogenesis. We also found, in the cDNA microarray data, that the human junctophilin-2 (JPH2) gene was the most highly expressed in the cementoblastoma; therefore, we used Western blotting to confirm the in vitro
    expression of JPH2, a special protein in cementoblastomas and cementoblasts.
    It might be a candidate molecule for a cementoblast marker. We hope that the
    results of this study will add to a detailed understanding of cementum biology
    and provide useful information for future clinical application.

    中文摘要……………………………………………………………………………………I 英文摘要………………………………………………………………………..…………III 致謝………………………………………………………………………………………...V 總目錄……………………………………………………………………………..………VI 表目錄…………………………………………………………………………………......IX 圖目錄…………………………………………………………………………...…………X 符號………………………………………………………………………………..………XI 第一章 序論......................................................................................................................... 1 一、簡介造牙骨質細胞瘤(cementoblastoma)....................................................... 1 二、牙骨質(cementum)在牙周再生的角色.......................................................... 2 三、牙骨質(cementum)的發育.............................................................................. 3 四、牙骨質(cementum)的組成與成分.................................................................. 5 五、牙骨質(cementum)和骨頭(bone)的異同.................................................. 5 六、牙骨質(cementum)可能的細胞標誌(cell markers)................................... 6 七、造骨細胞的胞外基質: BSP (Bone sialoprotein).................................................. 8 八、生物礦物質化(biological mineralization) ............................................................ 8 九、骨誘導培養液Osteogenic medium(OGM)........................................................... 9 九-1 β-glycerophosphate (BGP)............................................................................ 9 九-2 Ascorbic Acid.............................................................................................. 10 九-3 Dexamethasone........................................................................................... 10 十、鹼性磷酸酶與礦物質化的關係..........................................................................11 研究動機..................................................................................................................... 13 第二章 材料與方法........................................................................................................... 15 I.材料........................................................................................................................... 15 I-1 人類病理組織樣本....................................................................................... 15 I-2 人類初級培養細胞來源............................................................................... 15 I-3 細胞培養....................................................................................................... 15 I-4 試劑藥品....................................................................................................... 16 I-5 抗體............................................................................................................... 17 I-6 耗材............................................................................................................... 18 I-7 套裝實驗組................................................................................................... 18 I-8 儀器設備....................................................................................................... 19 II.方法......................................................................................................................... 20 VII II-1 實驗組織的取得.......................................................................................... 20 II-2 初級培養造牙骨質瘤細胞.......................................................................... 21 II-3 初級培養人類牙齦纖維母細胞.................................................................. 21 II-4 初級培養人類正常口腔角質細胞.............................................................. 22 II-5 初級培養人類牙周韌帶齦纖維母細胞...................................................... 23 II-6 初級培養牙骨質細胞-1............................................................................... 24 II-7 初級培養牙骨質細胞-2............................................................................... 24 II-8 細胞繼代培養.............................................................................................. 25 II-9 保存細胞...................................................................................................... 27 II-10 解凍細胞.................................................................................................... 27 II-11 細胞計數.................................................................................................... 28 II-12 Alizarin Red S Staining .............................................................................. 28 II-13 產生CAP(cementum attachment protein)多株抗體.................................. 29 II-14 CAP抗體純化 (total IgG) ......................................................................... 30 II-15 免疫組織染色(Immunohistochemistry)----石蠟包埋組織....................... 30 II-16 萃取細胞蛋白質........................................................................................ 32 II-17 蛋白質濃度測定........................................................................................ 33 II-18 SDS-PAGE蛋白質電泳 (SDS-PAGE protein electrophotresis) ............... 33 II-19 西方點墨法................................................................................................ 35 II-20 cDNA微矩陣分析(cDNA Microarray assay)前製作業............................ 36 II-21 RNA萃取................................................................................................... 36 II-22 RNA濃度測定........................................................................................... 37 II-23 鹼性磷酸酶活性分析alkaline phosphatase activity assay ........................ 37 II-24 統計方法................................................................................................... 38 第三章 實驗結果............................................................................................................... 39 I. 樣本的取得............................................................................................................. 39 II. 鑑定初級培養的細胞........................................................................................... 39 II-1. 初級培養的造牙骨質細胞瘤細胞(cementoblastoma cell) ...................... 39 II-2. 初級培養的人類牙齦纖維母細胞(human gingival fibroblast)................ 39 II-3. 初級培養的人類正常口腔角質細胞(normal oral keratinocyte).............. 40 II-4. 初級培養的牙周韌帶纖維母細胞(periodontal ligament fibroblast)........ 40 III. Osteoblast expression BSP-鑑定人類骨母細胞株.............................................. 40 IV. 鑑定所得到cementum attachment protein (CAP)抗體的純度及效度............... 41 V. cDNA microarray分析結果.................................................................................... 41 VI. 鑑定初級培養的造牙骨質細胞(normal cementoblast)...................................... 41 VII. Tumor susceptibility gene 101(TSG101)蛋白在cementoblastoma中大量表現 VIII ................................................................................................................................... 42 VIII.相較於其他正常細胞 cementoblastoma cells具較多量的alkaline phosphatase (ALP)活性.................................................................................................................. 42 IX.在cementoblastoma cells中junctophilin2 (JPH2)是一個有趣的蛋白.................. 42 X. Junctophilin2 (JPH2)is also expressed in cementoblast......................................... 43 第四章 結果討論............................................................................................................... 44 I.牙骨質細胞瘤(cementoblastoma)致病原因探討.................................................... 44 II.比較cementoblastoma cell及cementoblast ............................................................. 45 III.細胞的礦化............................................................................................................ 46 IV.骨標記在牙骨質生成的意義................................................................................ 46 V.Cementoblast細胞標誌的探討............................................................................... 48 參考文獻............................................................................................................................. 52 圖Figure…………………………………………………………………………………...60 表Table………………………………………………………………...……………..……81 附錄一............................................................................................................................... ..83 自述.................................................................................................................................... 84

    Alatli I, Lundmark C, Hammarstrom L (1996). The localization of epithelial root sheath
    cells during cementum formation in rat molars. J Periodontal Res 31(6):433-40.
    Alvarez-Perez MA, Narayanan S, Zeichner-David M, Rodriguez Carmona B, Arzate H
    (2006). Molecular cloning, expression and immunolocalization of a novel human
    cementum-derived protein (CP-23). Bone 38(3):409-19.
    Alvarez Perez MA, Pitaru S, Alvarez Fregoso O, Reyes Gasga J, Arzate H (2003).
    Anti-cementoblastoma-derived protein antibody partially inhibits mineralization on a
    cementoblastic cell line. J Struct Biol 143(1):1-13.
    Arzate H, Olson SW, Page RC, Gown AM, Narayanan AS (1992). Production of a
    monoclonal antibody to an attachment protein derived from human cementum. Faseb J
    6(11):2990-5.
    Aubin JE, Heersche JN, Merrilees MJ, Sodek J (1982). Isolation of bone cell clones with
    differences in growth, hormone responses, and extracellular matrix production. J Cell Biol
    92(2):452-61.
    Aukhil I (1991). Biology of tooth-cell adhesion. Dent Clin North Am 35(3):459-67.
    Banovac K, Koren E (2000). Triiodothyronine stimulates the release of membrane-bound
    alkaline phosphatase in osteoblastic cells. Calcif Tissue Int 67(6):460-5.
    Beresford JN, Joyner CJ, Devlin C, Triffitt JT (1994). The effects of dexamethasone and
    1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in
    vitro. Arch Oral Biol 39(11):941-7.
    Bianco P, Fisher LW, Young MF, Termine JD, Robey PG (1991). Expression of bone
    sialoprotein (BSP) in developing human tissues. Calcif Tissue Int 49(6):421-6.
    Biggs JT, Benenati FW (1995). Surgically treating a benign cementoblastoma while
    retaining the involved tooth. J Am Dent Assoc 126(9):1288-90.
    Birkedal-Hansen H, Butler WT, Taylor RE (1977). Proteins of the periodontium.
    Characterization of the insoluble collagens of bovine dental cementum. Calcif Tissue Res
    53
    23(1):39-44.
    Blumberg P, Brenner R, Budny S, Kresse H (1997). Increased turnover of small
    proteoglycans synthesized by human osteoblasts during cultivation with ascorbate and
    beta-glycerophosphate. Calcif Tissue Int 60(6):554-60.
    Boabaid F, Gibson CW, Kuehl MA, Berry JE, Snead ML, Nociti FH, Jr., Katchburian E,
    Somerman MJ (2004). Leucine-rich amelogenin peptide: a candidate signaling molecule
    during cementogenesis. J Periodontol 75(8):1126-36.
    Bosshardt DD, Zalzal S, McKee MD, Nanci A (1998). Developmental appearance and
    distribution of bone sialoprotein and osteopontin in human and rat cementum. Anat Rec
    250(1):13-33.
    Bronckers AL, Farach-Carson MC, Van Waveren E, Butler WT (1994).
    Immunolocalization of osteopontin, osteocalcin, and dentin sialoprotein during dental root
    formation and early cementogenesis in the rat. J Bone Miner Res 9(6):833-41.
    Chang JG, Su TH, Wei HJ, Wang JC, Chen YJ, Chang CP, Jeng CJ (1999). Analysis of
    TSG101 tumour susceptibility gene transcripts in cervical and endometrial cancers. Br J
    Cancer 79(3-4):445-50.
    Chen J, Shapiro HS, Sodek J (1992). Development expression of bone sialoprotein mRNA
    in rat mineralized connective tissues. J Bone Miner Res 7(8):987-97.
    Chen L, Scholler J, Foged NT (1996). ALP induction by beta-glycerophosphate during the
    non-mineralization phase in vitro. J Tongji Med Univ 16(1):20-4.
    Cheng H, Caterson B, Neame PJ, Lester GE, Yamauchi M (1996). Differential distribution
    of lumican and fibromodulin in tooth cementum. Connect Tissue Res 34(2):87-96.
    Christner P, Robinson P, Clark CC (1977). A preliminary characterization of human
    cementum collagen. Calcif Tissue Res 23(2):147-50.
    Cochran DL, Wozney JM (1999). Biological mediators for periodontal regeneration.
    Periodontol 2000 19(40-58.
    54
    Cundiff EJ, 2nd (2000). Developing cementoblastoma: case report and update of
    differential diagnosis. Quintessence Int 31(3):191-5.
    D'Errico JA, MacNeil RL, Takata T, Berry J, Strayhorn C, Somerman MJ (1997).
    Expression of bone associated markers by tooth root lining cells, in situ and in vitro. Bone
    20(2):117-26.
    Draper JS, Pigott C, Thomson JA, Andrews PW (2002). Surface antigens of human
    embryonic stem cells: changes upon differentiation in culture. J Anat 200(Pt 3):249-58.
    Fisher LW, Whitson SW, Avioli LV, Termine JD (1983). Matrix sialoprotein of developing
    bone. J Biol Chem 258(20):12723-7.
    Fleming P, Ryan D (2002). Benign cementoblastoma: a case report. J Ir Dent Assoc
    48(1):3-5.
    Fong CD, Slaby I, Hammarstrom L (1996). Amelin: an enamel-related protein, transcribed
    in the cells of epithelial root sheath. J Bone Miner Res 11(7):892-8.
    Ganss B, Kim RH, Sodek J (1999). Bone sialoprotein. Crit Rev Oral Biol Med
    10(1):79-98.
    Ganta DR, McCarthy MB, Gronowicz GA (1997). Ascorbic acid alters collagen integrins
    in bone culture. Endocrinology 138(9):3606-12.
    Gao J, Symons AL, Haase H, Bartold PM (1999). Should cementoblasts express alkaline
    phosphatase activity? Preliminary study of rat cementoblasts in vitro. J Periodontol
    70(9):951-9.
    Garrett S (1996). Periodontal regeneration around natural teeth. Ann Periodontol
    1(1):621-66.
    Glimcher MJ, Lefteriou B (1989). Soluble glycosylated phosphoproteins of cementum.
    Calcif Tissue Int 45(3):165-72.
    Grzesik WJ, Cheng H, Oh JS, Kuznetsov SA, Mankani MH, Uzawa K, Robey PG,
    Yamauchi M (2000). Cementum-forming cells are phenotypically distinct from
    55
    bone-forming cells. J Bone Miner Res 15(1):52-9.
    Hanash SM, Strahler JR, Kuick R, Chu EH, Nichols D (1988). Identification of a
    polypeptide associated with the malignant phenotype in acute leukemia. J Biol Chem
    263(26):12813-5.
    Harrison G, Shapiro IM, Golub EE (1995). The phosphatidylinositol-glycolipid anchor on
    alkaline phosphatase facilitates mineralization initiation in vitro. J Bone Miner Res
    10(4):568-73.
    Hunter GK, Poitras MS, Underhill TM, Grynpas MD, Goldberg HA (2001). Induction of
    collagen mineralization by a bone sialoprotein--decorin chimeric protein. J Biomed Mater
    Res 55(4):496-502.
    Ikezawa K, Ohtsubo M, Norwood TH, Narayanan AS (1998). Role of cyclin E and cyclin
    E-dependent kinase in mitogenic stimulation by cementum-derived growth factor in human
    fibroblasts. Faseb J 12(12):1233-9.
    Ivanovski S, Li H, Haase HR, Bartold PM (2001). Expression of bone associated
    macromolecules by gingival and periodontal ligament fibroblasts. J Periodontal Res
    36(3):131-41.
    Koike H, Uzawa K, Grzesik WJ, Seki N, Endo Y, Kasamatsu A, Yamauchi M, Tanzawa H
    (2005). GLUT1 is highly expressed in cementoblasts but not in osteoblasts. Connect Tissue
    Res 46(3):117-24.
    Komori T, Kishimoto T (1998). Cbfa1 in bone development. Curr Opin Genet Dev
    8(4):494-9.
    Koonin EV, Abagyan RA (1997). TSG101 may be the prototype of a class of dominant
    negative ubiquitin regulators. Nat Genet 16(4):330-1.
    Lekic P, McCulloch CA (1996). Periodontal ligament cell population: the central role of
    fibroblasts in creating a unique tissue. Anat Rec 245(2):327-41.
    Lekic P, Sodek J, McCulloch CA (1996). Osteopontin and bone sialoprotein expression in
    regenerating rat periodontal ligament and alveolar bone. Anat Rec 244(1):50-8.
    56
    Li X, Liu P, Liu W, Maye P, Zhang J, Zhang Y, Hurley M, Guo C, Boskey A, Sun L, Harris
    SE, Rowe DW, Ke HZ, Wu D (2005). Dkk2 has a role in terminal osteoblast differentiation
    and mineralized matrix formation. Nat Genet 37(9):945-52.
    Lu Q, Hope LW, Brasch M, Reinhard C, Cohen SN (2003). TSG101 interaction with HRS
    mediates endosomal trafficking and receptor down-regulation. Proc Natl Acad Sci U S A
    100(13):7626-31.
    Macneil RL, Sheng N, Strayhorn C, Fisher LW, Somerman MJ (1994). Bone sialoprotein is
    localized to the root surface during cementogenesis. J Bone Miner Res 9(10):1597-606.
    Marks SC, Jr., Popoff SN (1988). Bone cell biology: the regulation of development,
    structure, and function in the skeleton. Am J Anat 183(1):1-44.
    Maucuer A, Camonis JH, Sobel A (1995). Stathmin interaction with a putative kinase and
    coiled-coil-forming protein domains. Proc Natl Acad Sci U S A 92(8):3100-4.
    McKee MD, Zalzal S, Nanci A (1996). Extracellular matrix in tooth cementum and mantle
    dentin: localization of osteopontin and other noncollagenous proteins, plasma proteins, and
    glycoconjugates by electron microscopy. Anat Rec 245(2):293-312.
    Minamisawa S, Oshikawa J, Takeshima H, Hoshijima M, Wang Y, Chien KR, Ishikawa Y,
    Matsuoka R (2004). Junctophilin type 2 is associated with caveolin-3 and is
    down-regulated in the hypertrophic and dilated cardiomyopathies. Biochem Biophys Res
    Commun 325(3):852-6.
    Mornet E, Stura E, Lia-Baldini AS, Stigbrand T, Menez A, Le Du MH (2001). Structural
    evidence for a functional role of human tissue nonspecific alkaline phosphatase in bone
    mineralization. J Biol Chem 276(33):31171-8.
    Mosqueda-Taylor A, Ledesma-Montes C, Caballero-Sandoval S, Portilla-Robertson J,
    Ruiz-Godoy Rivera LM, Meneses-Garcia A (1997). Odontogenic tumors in Mexico: a
    collaborative retrospective study of 349 cases. Oral Surg Oral Med Oral Pathol Oral
    Radiol Endod 84(6):672-5.
    Mueckler M (1994). Facilitative glucose transporters. Eur J Biochem 219(3):713-25.
    57
    Mueckler M, Hresko RC, Sato M (1997). Structure, function and biosynthesis of GLUT1.
    Biochem Soc Trans 25(3):951-4.
    Narisawa S, Hofmann MC, Ziomek CA, Millan JL (1992). Embryonic alkaline
    phosphatase is expressed at M-phase in the spermatogenic lineage of the mouse.
    Development 116(1):159-65.
    Nishi M, Mizushima A, Nakagawara K, Takeshima H (2000). Characterization of human
    junctophilin subtype genes. Biochem Biophys Res Commun 273(3):920-7.
    Nishi M, Sakagami H, Komazaki S, Kondo H, Takeshima H (2003). Coexpression of
    junctophilin type 3 and type 4 in brain. Brain Res Mol Brain Res 118(1-2):102-10.
    Ochsenius G, Ortega A, Godoy L, Penafiel C, Escobar E (2002). Odontogenic tumors in
    Chile: a study of 362 cases. J Oral Pathol Med 31(7):415-20.
    Ohki K, Kumamoto H, Nitta Y, Nagasaka H, Kawamura H, Ooya K (2004). Benign
    cementoblastoma involving multiple maxillary teeth: report of a case with a review of the
    literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97(1):53-8.
    Orsini G, Fioroni M, Rubini C, Piattelli A (2001). Zebra XXI, Part 2. Cementoblastoma. J
    Endod 27(8):546-7.
    Piattelli A, D'Addona A, Piattelli M (1990). Benign cementoblastoma: review of the
    literature and report of a case at an unusual location. Acta Stomatol Belg 87(3):209-15.
    Piattelli A, Di Alberti L, Scarano A, Piattelli M (1998). Benign cementoblastoma
    associated with an unerupted third molar. Oral Oncol 34(3):229-31.
    Polson AM (1986). The root surface and regeneration; present therapeutic limitations and
    future biologic potentials. J Clin Periodontol 13(10):995-9.
    Pynn BR, Sands TD, Bradley G (2001). Benign cementoblastoma: a case report. J Can
    Dent Assoc 67(5):260-2.
    Saito M, Iwase M, Maslan S, Nozaki N, Yamauchi M, Handa K, Takahashi O, Sato S,
    58
    Kawase T, Teranaka T, Narayanan AS (2001). Expression of cementum-derived attachment
    protein in bovine tooth germ during cementogenesis. Bone 29(3):242-8.
    Saygin NE, Giannobile WV, Somerman MJ (2000). Molecular and cell biology of
    cementum. Periodontol 2000 24(73-98.
    Schroeder HE (1992). Biological problems of regenerative cementogenesis: synthesis and
    attachment of collagenous matrices on growing and established root surfaces. Int Rev Cytol
    142(1-59.
    Schroeder HE (1993). Human cellular mixed stratified cementum: a tissue with alternating
    layers of acellular extrinsic- and cellular intrinsic fiber cementum. Schweiz Monatsschr
    Zahnmed 103(5):550-60.
    Shamblott MJ, Axelman J, Wang S, Bugg EM, Littlefield JW, Donovan PJ, Blumenthal PD,
    Huggins GR, Gearhart JD (1998). Derivation of pluripotent stem cells from cultured
    human primordial germ cells. Proc Natl Acad Sci U S A 95(23):13726-31.
    Sobel A (1991). Stathmin: a relay phosphoprotein for multiple signal transduction? Trends
    Biochem Sci 16(8):301-5.
    Solheim E (1998). Growth factors in bone. Int Orthop 22(6):410-6.
    Sommer B, Bickel M, Hofstetter W, Wetterwald A (1996). Expression of matrix proteins
    during the development of mineralized tissues. Bone 19(4):371-80.
    Stiglbauer R, Steurer M, Schimmerl S, Kramer J (1992). MRI of cartilaginous tumours of
    the larynx. Clin Radiol 46(1):23-7.
    Taira M, Nakao H, Takahashi J, Araki Y (2003). Effects of two vitamins, two growth
    factors and dexamethasone on the proliferation of rat bone marrow stromal cells and
    osteoblastic MC3T3-E1 cells. J Oral Rehabil 30(7):697-701.
    Takeshima H, Komazaki S, Nishi M, Iino M, Kangawa K (2000). Junctophilins: a novel
    family of junctional membrane complex proteins. Mol Cell 6(1):11-22.
    Tenenbaum HC (1981). Role of organic phosphate in mineralization of bone in vitro. J
    59
    Dent Res 60 Spec No C(1586-9.
    Tenenbaum HC, Heersche JN (1982). Differentiation of osteoblasts and formation of
    mineralized bone in vitro. Calcif Tissue Int 34(1):76-9.
    Tenorio D, Cruchley A, Hughes FJ (1993). Immunocytochemical investigation of the rat
    cementoblast phenotype. J Periodontal Res 28(6 Pt 1):411-9.
    Terranova VP, Martin GR (1982). Molecular factors determining gingival tissue interaction
    with tooth structure. J Periodontal Res 17(5):530-3.
    Ulmansky M, Hjorting-Hansen E, Praetorius F, Haque MF (1994). Benign
    cementoblastoma. A review and five new cases. Oral Surg Oral Med Oral Pathol
    77(1):48-55.
    Uwanogho DA, Hardcastle Z, Balogh P, Mirza G, Thornburg KL, Ragoussis J, Sharpe PT
    (1999). Molecular cloning, chromosomal mapping, and developmental expression of a
    novel protein tyrosine phosphatase-like gene. Genomics 62(3):406-16.
    Wang J, Zhou J, Bondy CA (1999). Igf1 promotes longitudinal bone growth by insulin-like
    actions augmenting chondrocyte hypertrophy. Faseb J 13(14):1985-90.
    Yamamoto T, Hinrichsen KV (1993). The development of cellular cementum in rat molars,
    with special reference to the fiber arrangement. Anat Embryol (Berl) 188(6):537-49.
    Yamamoto T, Domon T, Takahashi S, Wakita M (1996). Cellular cementogenesis in rat
    molars: the role of cementoblasts in the deposition of intrinsic matrix fibers of cementum
    proper. Anat Embryol (Berl) 193(5):495-500.
    Yaszemski MJ, Payne RG, Hayes WC, Langer R, Mikos AG (1996). Evolution of bone
    transplantation: molecular, cellular and tissue strategies to engineer human bone.
    Biomaterials 17(2):175-85.

    下載圖示 校內:2007-06-29公開
    校外:2007-06-29公開
    QR CODE